The consolidated revenue from operations for Jubilant Foodworks Ltd (JFL), which operates fast-food chains Domino’s Pizza and Dunkin’ Donuts, has increased 13.4 per cent to ₹2,438.7 crore for the third quarter ended December 31, 2025. Its Standalone Revenue from Operations, which primarily consists of India revenue, was at ₹1,801.5 crore, up 11.8 per cent on year-on-year basis, said JFL, part of the Jubilant Bhartia Group, in its quarter preview for Q3/FY26. “During the quarter, 114 stores were added to the JFL group network, taking the total store count to 3,594 as of the end of the quarter,” the group said in a regulatory filing.
Beezaasan Explotech Ltd has completed the export of its products to a foreign country. The total value of the said export shipment is approximately ₹2.3 crore. This export reflects the company’s growing international presence and strengthens its position in overseas markets.
IRB Infrastructure and Developers (IRB) has posted a 12 per cent year-on-year rise in its toll revenue to ₹754 crore in December 2025. The revenue collection stood at ₹675 crore in the same month last year, IRB said in an exchange filing on Wednesday. The collection includes revenues from two of its InvITs, namely IRB InvIT Fund (Public InvIT) and IRB Infrastructure Trust (Private InvIT), the company added.
ACS Technologies Ltd has received a work order from Mahindra Defence Systems Ltd. This engagement represents a supply, installation, testing, commissioning, and integration (SITCI) contract for security and communication systems. The order value is ₹3,62,39,341.
Panacea Biotec Ltd has completed the enrolment of study participants (i.e., 10,335 study participants) in context of the DengiAll® Phase-III clinical trial. The company will continue to monitor each participant, post administration of the Investigational Medicinal Product (i.e., vaccine or Placebo), for a period of two years to examine the efficacy and immunogenicity of the vaccine.
NCL Industries has reported steady cement growth alongside segment-specific challenges for the quarter and nine months ended December 31, 2025. Core cement operations showed resilience with 5 per cent production and dispatch growth, while diversified segments faced volume pressures. Cement production rose 5 per cent YoY to 6,94,854 MT in Q3 FY26 from 6,61,049 MT, maintaining operational momentum. Dispatches followed suit at 6,93,229 MT, up 5 per cent YoY from 6,62,936 MT, reflecting balanced supply-demand dynamics. For 9M FY26, cement production reached 19,69,545 MT (up 3 per cent YoY) and dispatches hit 19,61,141 MT (up 2 per cent YoY), underscoring the segment’s role as NCL’s growth anchor amid infrastructure demand.
Gland Pharma Ltd (Gland or Company), a generic injectable & ophthalmic focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 per cent (OTC). The product is therapeutically equivalent to the reference listed drug (RLD), Pataday Once Daily Relief, 0.7%, of Alcon Laboratories Inc (Alcon).
Midwest has received a Quarry Lease Work Order from the Department of Mines & Geology, Andhra Pradesh. The company will undertake quarrying operations for extraction of Coloured Quartzite Blocks useful for cutting and polishing purposes over an extent of 21.012 Hectares (51.92 Acres) located at Survey No. 299, Hanumanthunipadu Village & Mandal, Prakasam district, for 30 years commencing from 6 January 2026 to 5 January 2056, subject to requisite statutory approvals and compliance with applicable conditions.
Niyogin Fintech has announced a strong performance update for the third quarter ended December 31, 2025. The company demonstrated resilience across core businesses amid evolving market dynamics in unsecured lending. Tashwinder Singh, CEO and Managing Director, said, “During the quarter, we delivered resilient performance across our core businesses, supported by strong execution and traction in our platform-led offerings. In light of evolving conditions in select unsecured lending segments, we adopted a more cautious approach to loan disbursements, while inking new partnerships to scale in the coming quarters.”
Published on January 8, 2026
